NMD4C Neuromuscular Talent Pool Launches Today!
Today, 5th May 2026, NMD4C officially launches our Neuromuscular Talent Pool, a new online resource developed to showcase neuromuscular trainees and research professionals across Canada who are seeking their next position or role in basic neuromuscular research.
The Neuromuscular Talent Pool is a searchable database of MSc and PhD students, postdoctoral fellows, technicians, and other research professionals who are actively seeking their next role in neuromuscular research. It is designed to support career transitions at all stages, such as progressing from an MSc to a PhD, from a PhD to a postdoctoral position, or moving between technical or research roles. By centralizing information on candidates’ experience and research interests, the platform increases the visibility of trainees and research professionals and helps laboratories, institutions, and research teams across Canada identify potential candidates more easily.
If you would like to be included in the Neuromuscular Talent Pool, you are invited to register by completing the short registration form below and uploading your CV along with a brief personal statement. The personal statement should outline your experience, your interest in neuromuscular research, and the type of position you are seeking next.
Register to Join the NMD4C Talent Pool
**Profiles included in the Talent Pool will be showcased for a period of three months.
**NMD4C will continue to share neuromuscular job opportunities through its website and social media channels. Laboratories or institutions wishing to promote available positions are welcome to submit job postings for posting and circulation.
For more information or to share a job opportunity, please contact our Communications Coordinator, Lola Owoeye.
Read next...
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.
Advancing AFC in Neuromuscular Medicine: Program Launch & September Workshop
The Royal College has approved National Training Standards for the AFC in Neuromuscular Medicine, creating a formal pathway to recognize enhanced competence with the DRCPSC credential. This designation establishes a national training standard, supports portable certification, and strengthens clinical capacity across Canada. PGME offices can now apply to offer accredited AFC programs, with a goal of five programs submitting applications by the end of 2026.